Year of Publication
Martin School of Public Policy and Administration
Master of Public Administration
Dr. Karen Blumenschein
Involuntary treatment is a lengthy legal process through which an individual that is deemed to be a danger to themselves or to others is forced to receive psychiatric treatment against their will. Often, involuntary treatment utilizes a medication called a long-acting injectable antipsychotic (LAI). With the rise of implicit bias awareness as of late, there has been new research showing that Black patients receive LAIs at disproportionate rates compared to White patients. There has not been research, however, to show the impact of diversity, equity, and inclusion (DEI) training of healthcare providers on the utilization rate of LAIs among the different races. This study used data collected from UK HealthCare to analyze the rate of LAI utilization and schizophrenia diagnosis among different demographics pre– and post–DEI training. Although a statistically significant difference between the two time periods was not found among White and Black patients, this study still highlighted a disproportionate rate of LAI utilization and schizophrenia diagnosis for Black patients. The results of this study show that DEI training in its current form may not be effective, and through involuntary treatment, the government may be perpetuating implicit biases.
Matthews, Hunter, "Forced Treatment Orders with Long-Acting Injectable Antipsychotics: Are They Forcing Implicit Biases?" (2022). MPA/MPP/MPFM Capstone Projects. 339.